Saskia Bresch

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 213 citations

Medicine, Surgery, Clinical Trials +1

Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability

Mikaël Cohen, Saskia Bresch, Océane Thommel Rocchi et al. · Multiple Sclerosis and Related Disorders · 2021 · 46 citations

Reliability, Intra Rater Reliability, Reliability Analysis +11

Therapeutic target of memory B cells depletion helps to tailor administration frequency of rituximab in myasthenia gravis

Christine Lebrun‐Frénay, Véronique Bourg, Saskia Bresch et al. · Journal of Neuroimmunology · 2016 · 44 citations

Immunology, Medicine, Cell Biology +2

Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders

Christine Lebrun‐Frénay, Mikaël Cohen, Maria Alessandra Rosenthal‐Allieri et al. · Neurology and Therapy · 2018 · 38 citations · Full text

Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes

Michaël Levraut, Antoine Gavoille, Cassandre Landes-Château et al. · Neurology Neuroimmunology & Neuroinflammation · 2023 · 36 citations · Full text